ArticleJournal of geriatric cardiology : JGC2026
Semaglutide ameliorates coronary microembolization-induced injury by suppressing apoptosis and inflammation via the HMGB1/RAGE/NF-κB p65 pathway.
Hua-Feng Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.